Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006742 |
---|---|
Receipt number | R000007966 |
Scientific Title | Efficacy and Safety study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the Japanese patient with Stage III curative resection Colon cancer -Phase II study |
Date of disclosure of the study information | 2011/11/20 |
Last modified on | 2021/05/25 15:54:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/11/17 20:58:02 | ||
2 | Update | 2012/02/01 10:01:50 | Organization Organization Division name Division name Address Address TEL Institute Institute Organization1 Address1 |
|
3 | Update | 2012/02/01 10:04:03 | Organization Organization Category of Funding Organization |
|
4 | Update | 2012/02/01 10:05:16 | Last name of contact person Last name of contact person |
|
5 | Update | 2016/07/06 16:39:22 | UMIN ID1 |
|
6 | Update | 2017/06/24 15:19:23 | Recruitment status Anticipated trial start date |
|
7 | Update | 2021/05/24 13:07:44 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Address Address TEL Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
8 | Update | 2021/05/24 13:10:02 | Date of IRB Last follow-up date |
|
9 | Update | 2021/05/24 13:10:43 | Number of participants that the trial has enrolled |
|
10 | Update | 2021/05/25 15:54:57 | UMIN ID2 |